A point-of-care diagnostics company enabling laboratory-quality molecular testing in minutes
nanopath.comLinkedInCambridge, Mass.Healthtech
5 sources · checked 1 time, last 25m ago
The $25 million financing includes $2 million in non-dilutive grant financing; the sources otherwise agree.
1 source
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B | $25M $25M financing total | 2026-11-10 | Norwest, SV Health Investors’ MedTech Convergence Fund | No recent discussion |
5 sources · checked 1 time, last 25m ago [ VERIFIED · CORRECTED ] read against 4 of 5 sources
The $25 million financing includes $2 million in non-dilutive grant financing; the sources otherwise agree. | ||||
| Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $10M | 2022-08-09 | Medtech Convergence Fund, Norwest | No recent discussion |
1 source [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: prnewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage | ||||